Physician profile
Ryan Bunch
NPI 1306225214
$5,225.58
in general payments reported to CMS, 2019-2025
22 companies · $1,644 in 2025
The $1,644 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2020: $52.88 · 2021: $472 · 2022: $395 · 2023: $1,112 · 2024: $1,285 · 2025: $1,644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,979 · Entertainment: $62.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,978.80 |
| Entertainment | $62.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $940.23 | 2021-2025 | Photrexa Viscous and Photrexa, Ce-Marked Kxla System, Idose |
| Johnson & Johnson Vision Care, INC. | $737.10 | 2022-2025 | Acuvue |
| Abbvie INC. | $736.22 | 2022-2025 | Vuity, Lumigan, Alphagan P |
| Alcon Vision LLC | $657.97 | 2019-2025 | Clareon, Hydrus Microstent, Total30 |
| Bausch & Lomb Americas INC. | $607.91 | 2022-2025 | Miebo, Vyzulta, Infuse |
| Biotissue Holdings INC. | $441.17 | 2021-2025 | |
| Rxsight INC | $205.40 | 2021-2025 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Omeros Corporation | $125.00 | 2019 | |
| Allergan, INC. | $120.99 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $103.75 | 2024-2025 | Xdemvy |
| Rayner Intraocular Lenses Limited | $95.45 | 2024 | Rayone Aspheric, Rayone Emv, Rayone Spheric |
| Coopervision INC. | $86.56 | 2021-2025 | Myday Contact Lens, Clariti Contact Lens |
| Regeneron Pharmaceuticals, INC. | $71.24 | 2023 | Eylea Hd |
| Optos, INC. | $62.38 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Eyevance Pharmaceuticals LLC | $38.97 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $37.83 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $35.19 | 2022-2025 | |
| Mallinckrodt Enterprises LLC | $32.21 | 2019 | |
| Ani Pharmaceuticals, INC. | $31.01 | 2024 | Purified Cortrophin Gel |
| Ocular Therapeutix, INC. | $27.57 | 2025 | Dextenza |
| Dompe US, INC. | $17.52 | 2025 | Oxervate |
| Carl Zeiss Meditec, INC. | $13.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Bunch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.